Back to Search Start Over

Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics.

Authors :
Voget R
Breidenbach J
Claff T
Hingst A
Sylvester K
Steinebach C
Vu LP
Weiße RH
Bartz U
Sträter N
Müller CE
Gütschow M
Source :
Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2024 May; Vol. 14 (5), pp. 2349-2357. Date of Electronic Publication: 2024 Mar 06.
Publication Year :
2024

Abstract

A titrant for the SARS-CoV-2 main protease (M <superscript>pro</superscript> ) was developed that enables, for the first time, the exact determination of the concentration of the enzymatically active M <superscript>pro</superscript> by active-site titration. The covalent binding mode of the tetrapeptidic titrant was elucidated by the determination of the crystal structure of the enzyme-titrant complex. Four fluorogenic substrates of M <superscript>pro</superscript> , including a prototypical, internally quenched Dabcyl-EDANS peptide, were compared in terms of solubility under typical assay conditions. By exploiting the new titrant, key kinetic parameters for the M <superscript>pro</superscript> -catalyzed cleavage of these substrates were determined.<br />Competing Interests: The authors declare no conflicts of interest.<br /> (© 2024 The Authors.)

Details

Language :
English
ISSN :
2211-3835
Volume :
14
Issue :
5
Database :
MEDLINE
Journal :
Acta pharmaceutica Sinica. B
Publication Type :
Academic Journal
Accession number :
38799620
Full Text :
https://doi.org/10.1016/j.apsb.2024.03.001